You are here: Industry Insights > Pfizer

News List

South Korea gives EUA for Pfizer’s oral coronavirus treatment ExpressPharma
December 28, 2021
South Korea authorised for emergency use Pfizer’s antiviral pills targeting COVID-19 as the first of its kind to be introduced in South Korea, said the Ministry of Food and Drug Safety.
Pfizer to deliver 2.5 million additional doses of Covid-19 pill to UK Pharmaceutical-Business-Review
December 24, 2021
The agreement with the Government of the UK is subject to the local authorisation of the Covid-19 pill.
Pfizer and BioNTech to Provide European Union More Than 200 Million Additional Doses of COMIRNATY® to Help Meet Continued Need for Vaccine Supply AmericanPharmaceuticalReview
December 22, 2021
Pfizer Inc. and BioNTech SE announced an agreement has been reached with the European Commission (EC) and its member states to exercise an option to purchase more than 200 million additional doses of COMIRNATY®...
EU to procure over 200 million doses of Pfizer-BioNTech’s Comirnaty Pharmaceutical-Technology
December 22, 2021
Pfizer and BioNTech have signed an agreement under which the European Commission (EC) and its member states will procure over 200 million additional doses of the companies’ Covid-19 vaccine Comirnaty.
Pfizer to provide UK with additional 2.5 treatment courses of Paxlovid pharmatimes
December 22, 2021
With authorisation, Pfizer’s oral antiviral candidate Paxlovid is an investigational SARS-CoV-2 protease inhibitor could be prescribed at the first sign of COVID-19 infection.
EMA’s CHMP adopts positive opinion for Pfizer’s and OPKO’s somatrogon for GHD treatment Pharmaceutical-Business-Review
December 21, 2021
A once-weekly long-acting recombinant human growth hormone, somatrogon is intended for treating children from three years of age and adolescents experiencing growth disturbance because of inadequate secretion of growth hormone.
Pfizer Vaccine Disappoints in Kids Ages 2 to 5 Drugs
December 20, 2021
Two doses of a pediatric Pfizer-BioNTech COVID-19 vaccine failed to spur an adequate immune response in children aged 2 to 5, the companies announced Friday.
Gene therapy sustains bleeding control in haemophilia A trial EuropeanPharmaceuticalReview
December 15, 2021
Giroctocogene fitelparvovec had a mean annualised bleeding rate (ABR) of just 1.4 percent over two years, with no bleeding events in the first year post infusion.
Pfizer Says Final Data Show COVID-19 Pill Stays Strong Against Severe Illness Drugs
December 15, 2021
Pfizer Inc. announced Tuesday that a final analysis shows its experimental antiviral pill Paxlovid sharply reduced hospitalizations and deaths among COVID-19 patients at high risk for severe illness.
Pfizer signs agreement to acquire Arena Pharmaceuticals for $6.7bn Pharmaceutical-Technology
December 15, 2021
Pfizer has signed a definitive agreement for the acquisition of all the outstanding shares of clinical-stage firm Arena Pharmaceuticals in a deal worth nearly $6.7bn or $100 for each share in cash.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page